{"id":"https://openalex.org/W4210328126","doi":"https://doi.org/10.3390/brainsci12020215","title":"Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION\u2015A 2-Year, Multicenter, Observational, Cohort Study","display_name":"Safety of Fingolimod in Patients with Multiple Sclerosis Switched from Natalizumab: Results from TRANSITION\u2015A 2-Year, Multicenter, Observational, Cohort Study","publication_year":2022,"publication_date":"2022-02-04","ids":{"openalex":"https://openalex.org/W4210328126","doi":"https://doi.org/10.3390/brainsci12020215","pmid":"https://pubmed.ncbi.nlm.nih.gov/35203978"},"language":"en","primary_location":{"id":"doi:10.3390/brainsci12020215","doi":"https://doi.org/10.3390/brainsci12020215","is_oa":true,"landing_page_url":"https://doi.org/10.3390/brainsci12020215","pdf_url":"https://www.mdpi.com/2076-3425/12/2/215/pdf?version=1644562471","source":{"id":"https://openalex.org/S122317144","display_name":"Brain Sciences","issn_l":"2076-3425","issn":["2076-3425"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain Sciences","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.mdpi.com/2076-3425/12/2/215/pdf?version=1644562471","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028230236","display_name":"Helmut Butzkueven","orcid":"https://orcid.org/0000-0003-3940-8727","observed_orcids":["https://orcid.org/0000-0003-3940-8727"]},"institutions":[{"id":"https://openalex.org/I2801993434","display_name":"The Alfred Hospital","ror":"https://ror.org/01wddqe20","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801993434","https://openalex.org/I4210163178"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Helmut Butzkueven","raw_affiliation_strings":["Department of Neurology, Alfred Hospital, Melbourne, VIC 3004, Australia","Department of Neuroscience, Monash University, Melbourne, VIC 3004, Australia"],"raw_orcid":"https://orcid.org/0000-0003-3940-8727","affiliations":[{"raw_affiliation_string":"Department of Neurology, Alfred Hospital, Melbourne, VIC 3004, Australia","institution_ids":["https://openalex.org/I2801993434"]},{"raw_affiliation_string":"Department of Neuroscience, Monash University, Melbourne, VIC 3004, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077635103","display_name":"Paul Steven Giacomini","orcid":"https://orcid.org/0000-0002-1346-3042","observed_orcids":["https://orcid.org/0000-0002-1346-3042"]},"institutions":[{"id":"https://openalex.org/I1292859797","display_name":"Montreal Neurological Institute and Hospital","ror":"https://ror.org/05ghs6f64","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I1292859797","https://openalex.org/I2801766832","https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I5023651","display_name":"McGill University","ror":"https://ror.org/01pxwe438","country_code":"CA","type":"education","lineage":["https://openalex.org/I5023651"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Paul S. Giacomini","raw_affiliation_strings":["Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3A 0G4, Canada","Multiple Sclerosis Clinic, Montreal Neurological Institute and Hospital, Montreal, QC H3A 2B4, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Neurosurgery, McGill University, Montreal, QC H3A 0G4, Canada","institution_ids":["https://openalex.org/I5023651"]},{"raw_affiliation_string":"Multiple Sclerosis Clinic, Montreal Neurological Institute and Hospital, Montreal, QC H3A 2B4, Canada","institution_ids":["https://openalex.org/I1292859797"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067317369","display_name":"STANLEY L. COHAN","orcid":"https://orcid.org/0000-0002-9568-346X","observed_orcids":["https://orcid.org/0000-0002-9568-346X"]},"institutions":[{"id":"https://openalex.org/I2801670537","display_name":"Providence Portland Medical Center","ror":"https://ror.org/015tmw922","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801670537","https://openalex.org/I4210160466","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stanley Cohan","raw_affiliation_strings":["Providence Multiple Sclerosis Center, Portland, OR 97225, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Providence Multiple Sclerosis Center, Portland, OR 97225, USA","institution_ids":["https://openalex.org/I2801670537"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114375542","display_name":"Tjalf Ziemssen","orcid":"https://orcid.org/0000-0001-8799-8202","observed_orcids":["https://orcid.org/0000-0001-8799-8202"]},"institutions":[{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Tjalf Ziemssen","raw_affiliation_strings":["Center of Clinical Neurosciences, University Hospital Carl Gustav Carus, 01307 Dresden, Germany"],"raw_orcid":"https://orcid.org/0000-0001-8799-8202","affiliations":[{"raw_affiliation_string":"Center of Clinical Neurosciences, University Hospital Carl Gustav Carus, 01307 Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086409600","display_name":"Daniel Sienkiewicz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Sienkiewicz","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100386099","display_name":"Ying Zhang","orcid":"https://orcid.org/0000-0002-2563-5606","observed_orcids":["https://orcid.org/0000-0002-2563-5606"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ying Zhang","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050790601","display_name":"Yvonne Geissb\u00fchler","orcid":"https://orcid.org/0000-0001-8528-6818","observed_orcids":["https://orcid.org/0000-0001-8528-6818"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Yvonne Geissb\u00fchler","raw_affiliation_strings":["Novartis Pharma AG, 4056 Basel, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-8528-6818","affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, 4056 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068676018","display_name":"Diego Silveira da Silva","orcid":"https://orcid.org/0000-0003-1289-6193","observed_orcids":["https://orcid.org/0000-0003-1289-6193"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Diego Silva","raw_affiliation_strings":["Novartis Pharma AG, 4056 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, 4056 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050196672","display_name":"Davorka Tomic","orcid":"https://orcid.org/0000-0002-1484-1850","observed_orcids":["https://orcid.org/0000-0002-1484-1850"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Davorka Tomic","raw_affiliation_strings":["Novartis Pharma AG, 4056 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, 4056 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000363730","display_name":"Harald Kropshofer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Harald Kropshofer","raw_affiliation_strings":["Novartis Pharma AG, 4056 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, 4056 Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023725739","display_name":"Mar\u00eda Trojano","orcid":"https://orcid.org/0000-0002-6329-8946","observed_orcids":["https://orcid.org/0000-0002-6329-8946"]},"institutions":[{"id":"https://openalex.org/I5561750","display_name":"University of Bari Aldo Moro","ror":"https://ror.org/027ynra39","country_code":"IT","type":"education","lineage":["https://openalex.org/I5561750"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Trojano","raw_affiliation_strings":["Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, 70121 Bari, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Basic Medical Sciences, Neurosciences and Sense Organs, University of Bari, 70121 Bari, Italy","institution_ids":["https://openalex.org/I5561750"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5028230236"],"corresponding_institution_ids":["https://openalex.org/I2801993434","https://openalex.org/I56590836"],"apc_list":{"value":2000,"currency":"CHF","value_usd":2094},"apc_paid":{"value":2000,"currency":"CHF","value_usd":2094},"fwci":1.1338,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.75508055,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"12","issue":"2","first_page":"215","last_page":"215"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11827","display_name":"Polyomavirus and related diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11308","display_name":"Sphingolipid Metabolism and Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fingolimod","display_name":"fingolimod","score":0.996999979019165},{"id":"https://openalex.org/keywords/natalizumab","display_name":"natalizumab","score":0.8700000047683716},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9779999852180481},{"id":"https://openalex.org/keywords/treatment-switching","display_name":"treatment switching","score":0.6769999861717224},{"id":"https://openalex.org/keywords/progressive-multifocal-leukoencephalopathy","display_name":"progressive multifocal leukoencephalopathy","score":0.9760000109672546},{"id":"https://openalex.org/keywords/relapse-rate","display_name":"relapse rate","score":0.8330000042915344},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.7960000038146973},{"id":"https://openalex.org/keywords/mri-disease-activity","display_name":"MRI activity","score":0.7559999823570251},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8560000061988831},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.7089999914169312},{"id":"https://openalex.org/keywords/real-world-safety","display_name":"real-world safety","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C2776036978","wikidata":"https://www.wikidata.org/wiki/Q425137","display_name":"Fingolimod","level":3,"score":0.9828374981880188},{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.9723004102706909},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8805683255195618},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.8251532912254333},{"id":"https://openalex.org/C2780892749","wikidata":"https://www.wikidata.org/wiki/Q929518","display_name":"Expanded Disability Status Scale","level":3,"score":0.7749533653259277},{"id":"https://openalex.org/C2780644213","wikidata":"https://www.wikidata.org/wiki/Q704930","display_name":"Progressive multifocal leukoencephalopathy","level":3,"score":0.7119400501251221},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.705817699432373},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5031301379203796},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4638189673423767},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3343096673488617},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.32493478059768677},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11065673828125}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.3390/brainsci12020215","doi":"https://doi.org/10.3390/brainsci12020215","is_oa":true,"landing_page_url":"https://doi.org/10.3390/brainsci12020215","pdf_url":"https://www.mdpi.com/2076-3425/12/2/215/pdf?version=1644562471","source":{"id":"https://openalex.org/S122317144","display_name":"Brain Sciences","issn_l":"2076-3425","issn":["2076-3425"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain Sciences","raw_type":"journal-article"},{"id":"pmid:35203978","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35203978","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain sciences","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8870332","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8870332","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Brain Sci","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:b3328938b1e14ae1a597adb3dfd8b852","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b3328938b1e14ae1a597adb3dfd8b852","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Brain Sciences, Vol 12, Iss 2, p 215 (2022)","raw_type":"article"},{"id":"pmh:oai:jupiter.its.unimelb.edu.au:11343/302705","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11343/302705","pdf_url":null,"source":{"id":"https://openalex.org/S4377196259","display_name":"Minerva Access (University of Melbourne)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I165779595","host_organization_name":"The University of Melbourne","host_organization_lineage":["https://openalex.org/I165779595"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.3390/brainsci12020215","doi":"https://doi.org/10.3390/brainsci12020215","is_oa":true,"landing_page_url":"https://doi.org/10.3390/brainsci12020215","pdf_url":"https://www.mdpi.com/2076-3425/12/2/215/pdf?version=1644562471","source":{"id":"https://openalex.org/S122317144","display_name":"Brain Sciences","issn_l":"2076-3425","issn":["2076-3425"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","norway-1","poland-100","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310310987","host_organization_name":"Multidisciplinary Digital Publishing Institute","host_organization_lineage":["https://openalex.org/P4310310987"],"host_organization_lineage_names":["Multidisciplinary Digital Publishing Institute"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Brain Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6399999856948853,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4210328126.pdf","grobid_xml":"https://content.openalex.org/works/W4210328126.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1986991730","https://openalex.org/W1997159649","https://openalex.org/W2019582599","https://openalex.org/W2023149067","https://openalex.org/W2043003871","https://openalex.org/W2103758700","https://openalex.org/W2104948944","https://openalex.org/W2118735809","https://openalex.org/W2133392888","https://openalex.org/W2149457184","https://openalex.org/W2151340435","https://openalex.org/W2162469926","https://openalex.org/W2168198006","https://openalex.org/W2196420394","https://openalex.org/W2344473058","https://openalex.org/W2538374410","https://openalex.org/W2540646744","https://openalex.org/W2569954169","https://openalex.org/W2610990451","https://openalex.org/W2745850917","https://openalex.org/W2748840293","https://openalex.org/W2756086242","https://openalex.org/W2796904335","https://openalex.org/W2810227481","https://openalex.org/W2876138996","https://openalex.org/W2962511891","https://openalex.org/W2996150345"],"related_works":["https://openalex.org/W2088205067","https://openalex.org/W2050459059","https://openalex.org/W3107840785","https://openalex.org/W2343984847","https://openalex.org/W2808580533","https://openalex.org/W2053484098","https://openalex.org/W2084518230","https://openalex.org/W4389460947","https://openalex.org/W2169569625","https://openalex.org/W4210328126"],"abstract_inverted_index":{"Multiple":[0],"sclerosis":[1],"(MS)":[2],"patients":[3,52,95,159,177,196],"receiving":[4],"natalizumab":[5,58,162],"and":[6,36,65,72,90,107,111,121,193],"who":[7],"are":[8],"at":[9],"risk":[10,28,148],"of":[11,46,127,149,181],"developing":[12],"progressive":[13],"multifocal":[14],"leukoencephalopathy":[15],"(PML)":[16],"often":[17],"switch":[18],"to":[19,42,163,190],"other":[20,73],"high-efficacy":[21],"disease-modifying":[22],"therapies":[23],"including":[24],"fingolimod":[25,47,185],"as":[26],"a":[27,60,145],"mitigation":[29],"strategy,":[30],"which":[31],"could":[32],"impact":[33],"treatment":[34,132],"safety":[35,45,64,167],"effectiveness.":[37],"The":[38,63,114],"TRANSITION":[39],"study":[40,100],"aimed":[41],"evaluate":[43],"the":[44,99],"over":[48],"two":[49],"years":[50],"in":[51,59,134,176,195],"with":[53,139,154,169,178],"MS":[54],"after":[55],"switching":[56,160],"from":[57,161,198],"real-world":[61],"setting.":[62],"effectiveness":[66,80],"were":[67,118,129,174],"assessed":[68,79],"by":[69,81],"monitoring":[70],"serious":[71],"adverse":[74],"events":[75],"(SAEs,":[76],"AEs).":[77],"We":[78],"recording":[82],"relapses,":[83],"Expanded":[84],"Disability":[85],"Status":[86],"Scale":[87],"(EDSS)":[88],"scores,":[89],"MRI":[91],"activity.":[92,137],"Of":[93],"637":[94],"enrolled,":[96],"505":[97],"completed":[98],"(mean":[101],"age,":[102],"42":[103],"years).":[104],"Overall,":[105],"72.8%":[106],"12.7%":[108],"experienced":[109],"AEs":[110,117],"SAEs":[112],"respectively.":[113],"most":[115],"common":[116],"fatigue,":[119],"headache,":[120],"urinary":[122],"tract":[123],"infection;":[124],"no":[125,165],"cases":[126],"PML":[128],"observed.":[130],"Fingolimod":[131,187],"resulted":[133],"low":[135,171],"disease":[136],"Patients":[138],"\u22648":[140,182],"weeks":[141,156,183],"washout":[142,179],"period":[143],"had":[144],"markedly":[146],"lower":[147],"relapses":[150],"(4.5%)":[151],"than":[152],"those":[153],">8":[155],"(51.4%).":[157],"In":[158],"fingolimod,":[164],"new":[166],"signals":[168],"overall":[170],"relapse":[172],"activity":[173],"observed":[175],"latencies":[180],"before":[184],"initiation.":[186],"was":[188],"found":[189],"be":[191],"safe":[192],"effective":[194],"transitioning":[197],"natalizumab.":[199]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":5}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}